- Home
- GOSS vs DOYU Comparison
GOSS vs DOYU Comparison
Compare GOSS & DOYU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- DOYU
- Stock Information
- Founded
- GOSS 2015
- DOYU 2014
- Country
- GOSS United States
- DOYU China
- Employees
- GOSS N/A
- DOYU N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- DOYU Computer Software: Programming Data Processing
- Sector
- GOSS Health Care
- DOYU Technology
- Exchange
- GOSS Nasdaq
- DOYU Nasdaq
- Market Cap
- GOSS 203.3M
- DOYU 206.3M
- IPO Year
- GOSS 2019
- DOYU 2019
- Fundamental
- Price
- GOSS $1.11
- DOYU $6.94
- Analyst Decision
- GOSS Strong Buy
- DOYU Sell
- Analyst Count
- GOSS 4
- DOYU 3
- Target Price
- GOSS $7.50
- DOYU $10.33
- AVG Volume (30 Days)
- GOSS 1.5M
- DOYU 63.4K
- Earning Date
- GOSS 05-20-2025
- DOYU 06-04-2025
- Dividend Yield
- GOSS N/A
- DOYU 280.00%
- EPS Growth
- GOSS N/A
- DOYU N/A
- EPS
- GOSS N/A
- DOYU N/A
- Revenue
- GOSS $114,701,000.00
- DOYU $585,116,720.00
- Revenue This Year
- GOSS N/A
- DOYU N/A
- Revenue Next Year
- GOSS $172.31
- DOYU N/A
- P/E Ratio
- GOSS N/A
- DOYU N/A
- Revenue Growth
- GOSS N/A
- DOYU N/A
- 52 Week Low
- GOSS $0.50
- DOYU $5.68
- 52 Week High
- GOSS $1.55
- DOYU $20.17
- Technical
- Relative Strength Index (RSI)
- GOSS 55.81
- DOYU 44.11
- Support Level
- GOSS $1.06
- DOYU $7.52
- Resistance Level
- GOSS $1.26
- DOYU $7.67
- Average True Range (ATR)
- GOSS 0.11
- DOYU 0.37
- MACD
- GOSS 0.03
- DOYU 0.09
- Stochastic Oscillator
- GOSS 67.95
- DOYU 34.81
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About DOYU DouYu International Holdings Limited ADS
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.